SCHEMBL25540689

SCHEMBL25540689

O=[N+]([O-])c1cc(-c2ccccc2)c(-n2c3ccccc3c3cc(-n4c5ccccc5c5cccc(-c6ccccc6)c54)ccc32)c(-c2ccccc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.41
POLB P06746 4/20 0.40
ATM Q13315 1/20 0.40
MEN1 O00255 6/20 0.39
KMT2A Q03164 6/20 0.39
LMNA P02545 1/20 0.39
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
CYP2C19 P33261 1/20 0.37
GFER P55789 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ALDH1A1 P00352 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25540515 0.91 MAPT (0.46) MAPTPOLBATMMEN1KMT2A
SCHEMBL25540691 0.91 MAPT (0.39) MAPTPOLBATMMEN1KMT2A
SCHEMBL25540557 0.87 MAPT (0.42) MAPTPOLBATMMEN1KMT2A
SCHEMBL25540699 0.83 DUSP3 (0.35) ATMMEN1KMT2AL3MBTL1GAA
SCHEMBL25540687 0.83 DUSP3 (0.35) MAPTATMMEN1KMT2ANPC1
SCHEMBL25540485 0.83 MAPT (0.47) MAPTPOLBATMMEN1KMT2A
SCHEMBL25540627 0.83 MAPT (0.37) MAPTPOLBATMMEN1KMT2A
SCHEMBL25540636 0.82 MAPT (0.44) MAPTPOLBATMMEN1KMT2A
SCHEMBL25539565 0.81 DUSP3 (0.34) ATML3MBTL1DUSP3
SCHEMBL12447612 0.80 L3MBTL1 (0.51) MAPTATMMEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159570-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159570-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND CRY1, CYP1A1, NQO1 MAPT 3198/4885POLB 3422/4885ATM 3960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.